Growth Needs Space: joimax, Inc. USA, is Moving Into Ne...( CAMPBELL California October 2 /- ...),Health
Navigation Links
Growth Needs Space: joimax, Inc. USA, is Moving Into New Premises
Date:10/2/2007
CAMPBELL, California, October 2 /PRNewswire/ -- joimax GmbH, Campbell, CA, is pleased to announce that due to increased space requirements by joimax, Inc. the company is moving to larger premises in Northern California where its US operations are based. As of October 1st, 2007 joimax, Inc. will be located at
joimax, Inc.
275 E. Hacienda Avenue
Campbell, CA 95008 USA
"This move reflects the strong growing activities on the US market," comments Michael Stek, CEO of the joimax, Inc. "Due to the increasing interest of potential new T(H)ESSYS(TM) users quick organizational build-up is taking place now," states Wolfgang Ries, President of joimax, Inc., Founder and Managing Director of the joimax GmbH. "This move represents the next logical step forward in the 'joimax Global Development Program'."
Further inquiries: joimax, Inc.
275 E. Hacienda Avenue
Campbell, CA 95008 USA
Phone: +1-408-370-3005
Fax: +1-408-370-3015
Mail: usa@joimax.com
'/>"/>
| SOURCE joimax GmbH Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. More The Usage More The Growth In The Adult Brain.
2. A new growth factor identified
3. Anthrax drug doxycycline could stunt fetal growth
4. Anti-Cancer Drug Restores Normal Cell Growth
5. Zinc may enhance growth in Young sickle cell patients
6. Drug stabilizes cancer growth
7. Enzyme stimulates growth of adult stem cells
8. Mental growth in babies at risk
9. Low-dose Growth Hormone (GH) with diet and exercise may help weight loss
10. New Molecule that can stop the growth of Viruses
11. Human Growth Hormone Found To be Dangerous For Human Use
Post Your Comments:
(Date:11/20/2009)... supply, study finds , , FRIDAY, Nov. 20...f prescription drugs is up to one-third cheaper th...tudy. , U.S. researchers analyzed 26,852 prescr..., and found that patients who bought a three-month...rage 29 percent in out-of-pocket costs. After the ...
(Date:11/20/2009)...ed to continue, CDC says, , , FRIDAY, N...d States are seeing declines in H1N1 swine flu act...while the disease remains widespread in 43 states,.... , "We are beginning to see some declines in i... still a lot of influenza everywhere," Dr. Anne Sc...
(Date:11/20/2009)...ased food insecurity as many face problem of hunge...- Project Bread, the state,s leading anti-hunger o...nual status report on hunger in the Commonwealth. ...aused by high unemployment, point to 554,000 peopl... insecurity has found its way into middle class su...
(Date:11/20/2009)... Omnicell, Inc. (Nasdaq:... acute healthcare facilities, announced today the ...fray Healthcare Conference at the New York Palace... Randall A. Lipps, founder, chairman, president &a..., Date: Tuesday, December 1, 2009 ,, Time: ...
(Date:11/20/2009)...wswire-USNewswire/ -- The Louisiana Association ...ans could experience higher health care premiums a...by Congress should become law. ,, According to ...siana health plans have supported comprehensive he...al debate. Our plans have offered significant cha...
Breaking Medicine News(10 mins):Health News:Three-Month Supply Lowers Drug Costs 2Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2[0] Three-Month Supply Lowers Drug Costs[0] Swine Flu Declining in Some Parts of U.S.[0] 554,000 in Massachusetts Struggle to Put Food on the Table[0] Omnicell to Present at Piper Jaffray Healthcare Conference[0] Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians
...shows amount in outer hair cell membranes affects ...ount of cholesterol in the outer hair cell membran... study concludes. , "We,ve known for a long time t...ing," senior author Dr. William Brownell, a profes...
...ars of follow-up, older women taking the newer dru...c. 14 (HealthDay News) -- The aromatase inhibitor ...d tamoxifen when it comes to preventing recurrence... a benefit, researchers said. , "It has been very...
...ber 14, 2007 A new review article from the journa...rug used to treat lymphoma, is now becoming used b...iseases. , Originally developed as the standard ...n dermatology and found that it successfully treat...
...c. 14 Veridex, LLC, a,Johnson & Johnson company, ...d the GeneSearch(TM) Breast Lymph Node (BLN) Assay..., In the December 24th issue of the magazine, ava... say, "doctors can,accurately test the sentinel no...
...ec. 14 The 10th Annual Customer,Experience Confer...ience,",sponsored by Best Practices, LLC,s Global ...ton Hotel in Phoenix, Ariz., Feb. 25-27, 2008. Thi...tition., Download "Using Quality to Improve the C...
... Combines Personal Responsibility and Public,Dolla...tt today announced the approval of a Medicaid waiv...nt an innovative health care proposal giving,appro...g applications for the new health care coverage, c...
Other Medicine News:Health News:Study Finds Cholesterol Fine-Tunes Hearing 2Health News:Arimidex Beats Tamoxifen in Keeping Breast Cancer at Bay 2Health News:Arimidex Beats Tamoxifen in Keeping Breast Cancer at Bay 3Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 2Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 3Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 4Health News:Reserve 2008 Budget for Using Quality to Improve the Customer Experience 2Health News:HHS Approves Medicaid Waiver to Create New Indiana Health Plan for Uninsured Hoosiers 2Study Finds Cholesterol Fine-Tunes HearingArimidex Beats Tamoxifen in Keeping Breast Cancer at BayLymphoma drug used to treat skin disordersTIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007Reserve 2008 Budget for Using Quality to Improve the Customer ExperienceHHS Approves Medicaid Waiver to Create New Indiana Health Plan for Uninsured Hoosiers
(Date:11/20/2009)...swire/ -- Reportlinker.com announces that a new ma.... ,, Pipettes & Pipettors - A Global Marke.../p0164373/Pipettes--Pipettors---A-Global-Market-Pe...m=pr&utm_campaign=prnewswire ,, Pipettes ...ny research laboratory. Large-scale applications i...
(Date:11/20/2009)...ov. 20 Boston Scientific...t has received 510(k) clearance from the U.S. Food...l to market its WallFlex® Fully Covered Esoph...eal strictures (obstructions) caused by tumors in ...eal cancer. ,, (Photo: http://www.newscom.co...
(Date:11/20/2009)...ewswire-FirstCall/ -- Smith & Nephew ( SNN, LS...e the signing of a technology development contract... may lead to the creation of a fracture fixation s...he limbs of soldiers who sustain battlefield injur...h Projects Agency (DARPA), the central research an...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 56087 1ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 56087 2Chindex International Announces September Investor Conferences Participation 56083 1Chindex International Announces September Investor Conferences Participation 56083 2Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 1Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 2Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 3Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 4Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 5...tho-McNeil Neurologics, a,division of Ortho-McNeil...at the U.S. Food and Drug Administration (FDA) has...iramate), based on studies submitted in,response t...use of TOPAMAX,in pediatric patients aged 1 to 24 ...to granting pediatric exclusivity, the FDA is cont...
...4 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) a...ase 3 clinical trial with AZ-004 (Staccato(R) loxa...eing developed for the treatment,of acute agitatio...er.,Alexza believes the novel, non-invasive nature...ng from inhaled loxapine administration via the,St...
Other Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |